Trials / Completed
CompletedNCT01210196
Sophisticated Assessment of Disease Burden in Patients With Fabry Disease
Sophisticated Assessment of Disease Burden in Patients With Fabry Disease - The SOPHIA in Fabry Disease Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 36 (actual)
- Sponsor
- Shire · Industry
- Sex
- All
- Age
- 25 Years
- Healthy volunteers
- Not accepted
Summary
To detect early signs of cardiac and metabolic alterations as well as to evaluate the progression of cardiac and metabolic impairments in mildly affected patients with Fabry Disease using high sensitive diagnostic methods.
Detailed description
Observational Study Evaluating the use of cardiac MRI with late enhancement technique, Echocardiography, 24h Holter ECG, plasma Lyso-Gb3 and urinary Gb3, to identify early signs of progressive Fabry Disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | MRI | Cardiac MRI after 12 and 24 months. |
Timeline
- Start date
- 2010-10-31
- Primary completion
- 2013-09-30
- Completion
- 2013-09-30
- First posted
- 2010-09-28
- Last updated
- 2021-06-03
Locations
11 sites across 6 countries: Belgium, Czechia, Denmark, Finland, Germany, Sweden
Source: ClinicalTrials.gov record NCT01210196. Inclusion in this directory is not an endorsement.